AR101750A1 - SOLID FORM OF (1-CYAN-CYCLOPROPIL) AMID OF ACID (2S, 4R) -4- [4- (1-METHYL-1H-PIRAZOL-4-IL) -2-TRIFLUOROMETIL-BENCENOSULFONIL] -1- (1- TRIFLUOROMETIL-CICLOPROPANOCARBONIL) PIRROLIDIN-2-CARBOXÍLICO - Google Patents
SOLID FORM OF (1-CYAN-CYCLOPROPIL) AMID OF ACID (2S, 4R) -4- [4- (1-METHYL-1H-PIRAZOL-4-IL) -2-TRIFLUOROMETIL-BENCENOSULFONIL] -1- (1- TRIFLUOROMETIL-CICLOPROPANOCARBONIL) PIRROLIDIN-2-CARBOXÍLICOInfo
- Publication number
- AR101750A1 AR101750A1 ARP150102816A ARP150102816A AR101750A1 AR 101750 A1 AR101750 A1 AR 101750A1 AR P150102816 A ARP150102816 A AR P150102816A AR P150102816 A ARP150102816 A AR P150102816A AR 101750 A1 AR101750 A1 AR 101750A1
- Authority
- AR
- Argentina
- Prior art keywords
- trifluorometil
- methyl
- acid
- solid form
- ciclopropanocarbonil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicación 1: Forma sólida de (1-ciano-ciclopropil)-amida de ácido (2S,4R)-4-[4-(1-metil-1H-pirazol-4-il)-2-trifluorometil-bencenosulfonil]-1-(1-trifluorometil-ciclopropanocarbonil)-pirrolidin-2-carboxílico, caracterizada por un patrón de difracción de rayos X de los polvos obtenido con una radiación Ka de Cu que presentaba picos característicos expresados en grados 2q en aproximadamente 8,7, 15,5, 17,5, 19,2 y 20,5.Claim 1: Solid form of (1-cyano-cyclopropyl) -amide acid (2S, 4R) -4- [4- (1-methyl-1 H -pyrazol-4-yl) -2-trifluoromethyl-benzenesulfonyl] -1 - (1-Trifluoromethyl-cyclopropanecarbonyl) -pyrrolidin-2-carboxylic acid, characterized by an X-ray diffraction pattern of the powders obtained with a Cu Ka radiation that had characteristic peaks expressed in 2q degrees at approximately 8.7, 15, 5, 17.5, 19.2 and 20.5.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14183700 | 2014-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR101750A1 true AR101750A1 (en) | 2017-01-11 |
Family
ID=51483334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150102816A AR101750A1 (en) | 2014-09-05 | 2015-09-03 | SOLID FORM OF (1-CYAN-CYCLOPROPIL) AMID OF ACID (2S, 4R) -4- [4- (1-METHYL-1H-PIRAZOL-4-IL) -2-TRIFLUOROMETIL-BENCENOSULFONIL] -1- (1- TRIFLUOROMETIL-CICLOPROPANOCARBONIL) PIRROLIDIN-2-CARBOXÍLICO |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR101750A1 (en) |
| TW (1) | TW201625593A (en) |
| WO (1) | WO2016034602A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI846731B (en) * | 2018-09-18 | 2024-07-01 | 瑞士商赫孚孟拉羅股份公司 | Use of a cathepsin s inhibitor against the formation of anti-drug antibodies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA106748C2 (en) * | 2009-04-20 | 2014-10-10 | Ф. Хоффманн-Ля Рош Аг | Proline derivatives as cathepsin inhibitors |
| MY167569A (en) * | 2011-11-11 | 2018-09-20 | Hoffmann La Roche | Process for the preparation of 1-acyl-4-phenylsulfonylprolinamide derivatives and new intermediates |
-
2015
- 2015-09-02 WO PCT/EP2015/069982 patent/WO2016034602A1/en not_active Ceased
- 2015-09-03 AR ARP150102816A patent/AR101750A1/en unknown
- 2015-09-04 TW TW104129411A patent/TW201625593A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016034602A1 (en) | 2016-03-10 |
| TW201625593A (en) | 2016-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU24462B1 (en) | DERIVATIVES OF PHENYLTRIAZOLE SUBSTITUTED WITH HYDROXYALKYL | |
| MY191581A (en) | Anti-pd-1 antibodies | |
| MX2017004539A (en) | Heterophasic polypropylene with improved impact strength/stiffness balance, improved powder flowability, reduced emissions and low shrinkage. | |
| CR20200274A (en) | Fungicidal oxadiazoles | |
| WO2016094837A3 (en) | Anti-c10orf54 antibodies and uses thereof | |
| MX2019009842A (en) | Solid composition comprising amorphous sofosbuvir. | |
| CL2016001587A1 (en) | Derivative based on 1,2-naphthoquinone and method of preparation thereof. | |
| MY193650A (en) | Extracellular matrix compositions | |
| SG11201709426XA (en) | Resin composition, film produced by using the resincomposition, and multilayer structure | |
| GB201602974D0 (en) | Engineered cells & methods (1) | |
| WO2016089886A3 (en) | Methods for treating dry eye disease by administering an il-6r antagonist | |
| EA201692154A1 (en) | OVERALL FALLING FILM | |
| JP2015173751A5 (en) | ||
| JP2015016294A5 (en) | ||
| CL2018001715A1 (en) | CFR regulators and methods for use | |
| EP3588637A4 (en) | Resin for energy device electrode, composition for forming energy device electrode, energy device electrode, and energy device | |
| MX2017006712A (en) | Matrix metalloproteinase production inhibitor. | |
| MX2016013439A (en) | Solid forms of a pharmaceutically active compound. | |
| CL2018001716A1 (en) | CFR regulators and methods for use | |
| AR101750A1 (en) | SOLID FORM OF (1-CYAN-CYCLOPROPIL) AMID OF ACID (2S, 4R) -4- [4- (1-METHYL-1H-PIRAZOL-4-IL) -2-TRIFLUOROMETIL-BENCENOSULFONIL] -1- (1- TRIFLUOROMETIL-CICLOPROPANOCARBONIL) PIRROLIDIN-2-CARBOXÍLICO | |
| AU2016345054A8 (en) | Apparatus for storing organic material | |
| WO2017061544A8 (en) | Radiation-damage-compensation-circuit and soi-mosfet | |
| MX2016010662A (en) | Compounds for improving cognition and social behavior in humans having neurological disorders. | |
| JP2015226493A5 (en) | ||
| IT201700003232A1 (en) | "IMPROVED PRESS BRAKE" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |